Polaris AI Pharma Corp. (KOSDAQ:041910)
South Korea · Delayed Price · Currency is KRW 6,460.00
-180.00 (-2.71%)
At close: Feb 13, 2026
Polaris AI Pharma Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
Period Ending | Sep '22 Sep 30, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 |
Net Income | 989.48 | 6,875 | 15,733 | 15,228 | 6,590 | 2,726 |
Depreciation & Amortization | 2,617 | 2,674 | 2,675 | 2,747 | 2,738 | 3,716 |
Loss (Gain) From Sale of Assets | -61.13 | -53.58 | -17.71 | 16.06 | -504.42 | 6.62 |
Asset Writedown & Restructuring Costs | - | - | 1,020 | - | - | - |
Loss (Gain) From Sale of Investments | 3,672 | 288.7 | -12,098 | -13,622 | -4,942 | -1,854 |
Loss (Gain) on Equity Investments | 296.96 | -2,362 | -156.36 | - | - | - |
Provision & Write-off of Bad Debts | 75.22 | -3.62 | -215.29 | -40.47 | -15.89 | -33.9 |
Other Operating Activities | -1,173 | 430.62 | -1,425 | 3,333 | 1,056 | 750.66 |
Change in Accounts Receivable | -4,454 | -2,790 | -1,029 | -2,218 | -440.24 | 1,321 |
Change in Inventory | -4,599 | -1,996 | -1,504 | -1,278 | 3,005 | 1,175 |
Change in Accounts Payable | 329.85 | -1,563 | 2,498 | 2,902 | -1,044 | -527.91 |
Change in Other Net Operating Assets | -568.44 | -896 | -770.88 | -2,777 | 806.81 | -288.93 |
Operating Cash Flow | -2,873 | 603.42 | 4,709 | 4,290 | 7,250 | 6,990 |
Operating Cash Flow Growth | - | -87.19% | 9.76% | -40.83% | 3.72% | -14.62% |
Capital Expenditures | -1,821 | -1,998 | -2,199 | -1,125 | -466.07 | -691.73 |
Sale of Property, Plant & Equipment | 182.55 | 140.04 | 31 | 158.91 | 8.18 | - |
Sale (Purchase) of Intangibles | 990.52 | -52.08 | -86.65 | -2,013 | 167.06 | -279.7 |
Investment in Securities | -8,972 | 7,120 | 902.16 | 14,148 | -553.06 | 2,352 |
Other Investing Activities | 467.26 | 440.95 | 429.25 | 520.1 | 1,777 | 147.67 |
Investing Cash Flow | -9,153 | 5,650 | -922.8 | 11,690 | 932.69 | 1,528 |
Short-Term Debt Issued | - | - | - | - | - | 2,000 |
Total Debt Issued | - | - | - | - | - | 2,000 |
Short-Term Debt Repaid | - | - | - | - | - | -9,000 |
Long-Term Debt Repaid | - | -247.31 | -257.29 | -226.15 | -6,000 | - |
Total Debt Repaid | -253.9 | -247.31 | -257.29 | -226.15 | -6,000 | -9,000 |
Net Debt Issued (Repaid) | -253.9 | -247.31 | -257.29 | -226.15 | -6,000 | -7,000 |
Issuance of Common Stock | - | - | - | - | 1,100 | 2,400 |
Repurchase of Common Stock | - | - | - | - | - | -676.41 |
Dividends Paid | -1,168 | -1,168 | -1,168 | -584 | -577.9 | -564.25 |
Other Financing Activities | - | - | - | -16.13 | -94.11 | -247.39 |
Financing Cash Flow | -1,422 | -1,415 | -1,425 | -826.28 | -5,572 | -6,088 |
Foreign Exchange Rate Adjustments | -21.37 | 93.83 | -162.26 | -10.72 | -151.38 | -1,432 |
Net Cash Flow | -13,470 | 4,932 | 2,198 | 15,143 | 2,459 | 997.83 |
Free Cash Flow | -4,694 | -1,395 | 2,510 | 3,165 | 6,784 | 6,298 |
Free Cash Flow Growth | - | - | -20.68% | -53.35% | 7.71% | -3.75% |
Free Cash Flow Margin | -7.34% | -2.31% | 4.09% | 6.81% | 16.82% | 16.48% |
Free Cash Flow Per Share | -401.90 | -119.41 | 214.91 | 270.94 | 573.07 | 540.59 |
Cash Interest Paid | - | - | - | 16.13 | 94.11 | 247.39 |
Cash Income Tax Paid | 1,576 | 1,866 | 4,824 | 1,792 | -542.61 | 1,077 |
Levered Free Cash Flow | -4,305 | -1,974 | 868.62 | 4,074 | 5,584 | 5,106 |
Unlevered Free Cash Flow | -4,292 | -1,970 | 875.62 | 4,084 | 5,639 | 5,246 |
Change in Working Capital | -9,291 | -7,245 | -806.14 | -3,371 | 2,328 | 1,679 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.